When Should We Start Sodium –Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention

When Should We Start Sodium –Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention Sodium–glucose co-transporter (SGLT2) inhibitors were primarily developed as anti-diabetic drugs to increase the excretion of glucose in the urine. However, SGLT2 inhibitor s have been reported to have multifactorial effects, such as renal protection and improvement of myocardial energy metabolism and anaemia symptoms, which may exert protection a...
Source: Radcliffe Cardiology - Category: Cardiology Authors: Source Type: research